Reactivation of COVID-19 pneumonia: A report of two cases.
作者信息
Ravioli Svenja, Ochsner Hannah, Lindner Gregor
机构信息
Department of Internal and Emergency Medicine, Buergerspital Solothurn, Solothurn, Switzerland.
Department of Internal and Emergency Medicine, Buergerspital Solothurn, Solothurn, Switzerland.
出版信息
J Infect. 2020 Aug;81(2):e72-e73. doi: 10.1016/j.jinf.2020.05.008. Epub 2020 May 7.
Abstract
摘要
相似文献
1
Reactivation of COVID-19 pneumonia: A report of two cases.新型冠状病毒肺炎复阳：两例报告
J Infect. 2020 Aug;81(2):e72-e73. doi: 10.1016/j.jinf.2020.05.008. Epub 2020 May 7.
2
Imatinib for COVID-19: A case report.伊马替尼治疗新型冠状病毒肺炎：一例病例报告。
Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27.
3
"Reversed halo sign" on 3D CT in COVID-19.新型冠状病毒肺炎三维CT上的“反晕征”
Diagn Interv Radiol. 2020 Jul;26(4):379. doi: 10.5152/dir.2020.20254.
4
Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?新冠病毒肺炎中糖皮质激素诱导的细菌性心内膜炎——值得关注吗？
Circ J. 2020 Sep 25;84(10):1887. doi: 10.1253/circj.CJ-20-0462. Epub 2020 Aug 7.
5
Case Report: Death due to COVID-19 in Three Brothers.病例报告：三兄弟因 COVID-19 死亡。
Am J Trop Med Hyg. 2020 Jun;102(6):1203-1204. doi: 10.4269/ajtmh.20-0240.
6
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.羟氯喹啉和阿奇霉素作为新型冠状病毒肺炎的潜在治疗药物；临床状况影响治疗结果。
J Pharmacokinet Pharmacodyn. 2020 Jun;47(3):187-188. doi: 10.1007/s10928-020-09689-x. Epub 2020 May 13.
7
Acute meningoencephalitis in a patient with COVID-19.一名新冠肺炎患者出现急性脑膜脑炎。
Rev Neurol (Paris). 2020 Jun;176(6):519-521. doi: 10.1016/j.neurol.2020.04.014. Epub 2020 May 11.
8
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.利托那韦和洛匹那韦在一名感染新型冠状病毒肺炎患者中诱导红细胞凋亡。
Blood. 2020 Aug 13;136(7):915. doi: 10.1182/blood.2020006228.
9
[Not Available].[不可用]。
Rev Med Suisse. 2020 Apr 15;16(690):756-757.
10
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.在中重度新型冠状病毒肺炎中使用阿那白滞素靶向炎症级联反应：病例系列
Ann Rheum Dis. 2020 Oct;79(10):1381-1382. doi: 10.1136/annrheumdis-2020-217706. Epub 2020 May 6.
引用本文的文献
1
Impacts of Covid-19 & black fungus on diabetes patients in India.新冠疫情和黑真菌对印度糖尿病患者的影响。
Afr Health Sci. 2023 Sep;23(3):422-430. doi: 10.4314/ahs.v23i3.49.
2
Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination.尽管基于原型的疫苗接种反复进行，但在 BA.5/ BF.7 突破性感染后，针对奥密克戎亚变种的中和作用随着病毒进化和老化而减弱。
Emerg Microbes Infect. 2023 Dec;12(2):2249121. doi: 10.1080/22221751.2023.2249121. Epub 2023 Sep 5.
3
Characteristics of re-admitted adult patients infected with severe acute respiratory syndrome Coronavirus 2 After initial hospitalization at King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.沙特阿拉伯塔布克的国王萨勒曼武装部队医院初次住院后再次入院的成人严重急性呼吸综合征冠状病毒 2 感染患者的特征。
Saudi Med J. 2023 Jul;44(7):647-654. doi: 10.15537/smj.2023.44.7.20220713.
4
Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection.了解新冠疫苗和治疗方案面临的挑战、群体免疫以及再次感染的可能性。
J Taibah Univ Med Sci. 2023 Jun;18(3):600-638. doi: 10.1016/j.jtumed.2022.11.007. Epub 2022 Dec 17.
5
Evidence of SARS-CoV-2 reinfection: analysis of 35,000 subjects and overview of systematic reviews.SARS-CoV-2 再感染的证据：对 35000 名受试者的分析和系统评价综述。
Clin Exp Med. 2023 Aug;23(4):1213-1224. doi: 10.1007/s10238-022-00922-0. Epub 2022 Oct 26.
6
Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.COVID-19 复发患者的临床表现、治疗选择和合并症：系统评价。
J Clin Lab Anal. 2022 May;36(5):e24402. doi: 10.1002/jcla.24402. Epub 2022 Apr 8.
7
Persisting Symptoms After COVID-19.新冠病毒感染后持续存在的症状。
Dtsch Arztebl Int. 2022 Mar 11;119(10):167-174. doi: 10.3238/arztebl.m2022.0147.
8
A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines.关于严重急性呼吸综合征冠状病毒2型缓解的系统评价：对其管理、治疗、免疫策略和治疗后指南的新挑战。
New Microbes New Infect. 2022 Jan;45:100949. doi: 10.1016/j.nmni.2022.100949. Epub 2022 Jan 7.
9
Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy.SARS-CoV-2 与心肌细胞的相互作用：心脏损伤和药物治疗潜在分子机制的研究进展。
Biomed Pharmacother. 2022 Feb;146:112518. doi: 10.1016/j.biopha.2021.112518. Epub 2021 Dec 9.
10
COVEVOL: Natural Evolution at 6 Months of COVID-19.COVEVOL：COVID-19 感染后 6 个月的自然进化。
Viruses. 2021 Oct 25;13(11):2151. doi: 10.3390/v13112151.
本文引用的文献
1
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.严重急性呼吸综合征冠状病毒 2 再激活的临床特征。
J Infect. 2020 May;80(5):e14-e17. doi: 10.1016/j.jinf.2020.03.001. Epub 2020 Mar 20.
Zotero 插件